RT Journal Article
SR Electronic
T1 780 VISTA-101 – A phase 1/2 clinical trial of KVA12123, an engineered IgG1 targeting VISTA, alone and in combination with pembrolizumab in advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A877
OP A877
DO 10.1136/jitc-2023-SITC2023.0780
VO 11
IS Suppl 1
A1 Iadonato, Shawn
A1 Ovechkina, Yulia
A1 Lustig, Kurt
A1 Hayreh, Vinny
A1 Guillaudeux, Thierry
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A877.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.